Trial intelligence / Profile preview

Factors Influencing Oral Vaccine Immunogenicity in Bangladeshi Children

NCT01019083Phase 2Completed

Sponsor
icddr,b
Start
Feb 2008
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zinc, albendazole, secnidazole in cholera, typhoid fever, sponsored by icddr,b. Started Feb 2008; status: completed.

02

Drugs

zincalbendazolesecnidazole
03

Conditions

choleratyphoid fever

Beyond the preview

Go deeper on NCT01019083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01019083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call